Member Info for RorkesDrift

Wow. Brilliant. Going do dig the chords out.

I mean cords.

In terms of the current song post trend why haven't we had The Cure. Are we waiting for the Vaccines?

The real question is "Who reported you".

His Lordship, in the donkey stable with a Weatherby Whaler extra large battering sausage?

Next you will be banning decorations outside Chav houses

Be good to find Patient info / consent.

Fingers crossed but not sure about it. I quote "Patients with Covid-19 have a mortality rate of about 35 ~ 50%".

Study is in mild to moderate patients but 2dry outcomes such a a/A ratio are measures for ventilated / cpap.

But hey its 6 patients - first in man so step forward. Good find. Thank you.

What Afama said. Plus how many active infections would you pick up using say a standard pregnancy test kit. I'm guessing 0.

So imagine a two by two grid - the sort favoured by Northern Business Schools. Let's call our a Bradford Box. Column are covid +ve and covid -ve. The rows are the test results. One box is covid +ve and picked up. You get the drift. I'm saying the same thing as afama but nodding my head sage like at the same time.

https://youtu.be/god7hAPv8f0

What is the next RNS anyway. The LFD is the highest priority but for that I've lost track. Is it

1. We now have technology
2. We have the right tooling to transfer the technology
3. We have trsnsfered the technology and will begin pilot batches
4. We have pilot batches and will lab test them
5. We have batches and will now start clinical testing
6. We have completed tech transfer and clinical testing and can now start selling

Our timeline exspurt hasn't DONE much on this but my guess is tech transfer has worked in that we have an LFD. It doesn't work with saliva so we are switching to nasal. The company is going to start clinical validation in Neath.

Fingers crossed.

Interferons are canonical host antiviral signalling mediators, and
stimulate release of many essential components of the early host
response to viral infection.30 Consistent with a beneficial role for type
I interferons, increased expression of the interferon receptor subunit
IFNAR2 reduced the odds of severe Covid-19 with Mendelian randomi?sation discovery p = 0.0043 (7 tests); replication p = 7.5 × 10-4 (1 test).
Within the assumptions of Mendelian randomisation, this represents
evidence for a protective role for IFNAR2 in Covid-19. Rare loss-of?function mutations in IFNAR2 are associated with severe Covid-1912 and
many other viral diseases.31,32 This suggests that adminstration of inter?feron may reduce the probability of critical illness in Covid-19, but our
evidence cannot distinguish when in illness such a treatment may be
effective. Exogenous interferon treatment did not reduce mortality in
hospitalised patients in a large scale clinical trial,33 suggesting that this
genetic effect may be mediated during the early phase of disease when
viral load is high

Actual paper

https://www.nature.com/articles/s41586-020-03065-y

You know what we might be on to something. Whisky.

I'm hoping I can get it on prescription

Hope you are right but just remind me how much has the wife of Zeus guy made following her insightful investmemt at 18p

Full Angela Lansbury. I'm googling it now. I get what you say

3rd June share price has fallen from £2+ at end of May to about £1.50.

LSE has post that fund raise is imminent at 1.20

4th June. RNS about placing. Those buying in previous week make loses whilst those shorting Avacta have made profits. Avacta aware of significant SP movement and PI concern but do not issue comment.

AS and board continue to propose option schemes for themselves prior to AGM

Taking a view on the CEO if you are invested?

April 2nd Boo hoo brothers and some blokes wife are able to buy £2M at 18p. Its not clear what information they are provided with. No news provided to market.

8th April - Cytiva and C19 test announced. Share price responds. The boo hoo brothers and the mans wife make an immediate profit.

Completely unrelated to this the tie up with boo hook is announced on 20th May.

I think we are being a bit unfair Sage. He has only had six years to bring a commercially viable product using affirmers to market. Its not as if he said it will be ready really soon and then let his mates (those who pick non execs) in at say 40% discount to the existing share spruce two weeks after he stated no NEED for additional funds.

Point 2. You need to understand the difference between saying " we have no plans to raise any finance" and actually meaning "we are actively in discussion about raising more money and have been for over a year. We keep our options open".

Heaven knows.....

Lol I think A5 needs some adjustment

I’m going to continue to update the market as and when - this may be after other people know (boo hoo brothers, turnip hope friends and family group, sequoi tiles and flooring) but be rest assured that any price movement immediately prior to this is coincidental as was my shedding of 30% of my holding just before it became apparent that none of the muliple avenues we are exploring as actually reached clinical testing. Insert waffle from here...

we meet major development and commercial milestones, when there’s material new information to provide to the market. And clearly there’s a lot going on right now in Avacta Group so I don’t imagine it’ll be that long before we speak again."